nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—Carbamazepine—epilepsy syndrome	0.218	0.52	CrCtD
Magnesium salicylate—Oxcarbazepine—epilepsy syndrome	0.201	0.48	CrCtD
Magnesium salicylate—PTGS2—epilepsy syndrome	0.0654	0.529	CbGaD
Magnesium salicylate—ALB—epilepsy syndrome	0.0583	0.471	CbGaD
Magnesium salicylate—Nepafenac—Carbamazepine—epilepsy syndrome	0.0306	0.148	CrCrCtD
Magnesium salicylate—Nepafenac—Oxcarbazepine—epilepsy syndrome	0.0282	0.137	CrCrCtD
Magnesium salicylate—ALB—Oxcarbazepine—epilepsy syndrome	0.0272	0.166	CbGbCtD
Magnesium salicylate—Carbamazepine—Phenytoin—epilepsy syndrome	0.027	0.131	CrCrCtD
Magnesium salicylate—ALB—Fosphenytoin—epilepsy syndrome	0.0238	0.145	CbGbCtD
Magnesium salicylate—Carbamazepine—Oxcarbazepine—epilepsy syndrome	0.0229	0.111	CrCrCtD
Magnesium salicylate—ALB—Clonazepam—epilepsy syndrome	0.0215	0.131	CbGbCtD
Magnesium salicylate—Salsalate—Carbamazepine—epilepsy syndrome	0.0211	0.102	CrCrCtD
Magnesium salicylate—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.0211	0.102	CrCrCtD
Magnesium salicylate—Salsalate—Oxcarbazepine—epilepsy syndrome	0.0195	0.0943	CrCrCtD
Magnesium salicylate—Oxcarbazepine—Clobazam—epilepsy syndrome	0.0187	0.0904	CrCrCtD
Magnesium salicylate—ALB—Rufinamide—epilepsy syndrome	0.0176	0.107	CbGbCtD
Magnesium salicylate—Oxcarbazepine—Diazepam—epilepsy syndrome	0.0174	0.084	CrCrCtD
Magnesium salicylate—PTGS1—Diazepam—epilepsy syndrome	0.0174	0.106	CbGbCtD
Magnesium salicylate—ALB—Phenytoin—epilepsy syndrome	0.0153	0.0937	CbGbCtD
Magnesium salicylate—ALB—Propofol—epilepsy syndrome	0.0143	0.0874	CbGbCtD
Magnesium salicylate—PTGS1—Valproic Acid—epilepsy syndrome	0.0137	0.0836	CbGbCtD
Magnesium salicylate—ALB—Diazepam—epilepsy syndrome	0.013	0.0792	CbGbCtD
Magnesium salicylate—Carbamazepine—SCN9A—epilepsy syndrome	0.000201	0.151	CrCbGaD
Magnesium salicylate—Carbamazepine—SCN4A—epilepsy syndrome	0.000185	0.139	CrCbGaD
Magnesium salicylate—Trisalicylate-choline—PTGS2—epilepsy syndrome	0.000158	0.119	CrCbGaD
Magnesium salicylate—Ketoprofen—SLCO1A2—epilepsy syndrome	0.000132	0.0991	CrCbGaD
Magnesium salicylate—Salicylate-sodium—PTGS2—epilepsy syndrome	9.6e-05	0.0722	CrCbGaD
Magnesium salicylate—Nepafenac—PTGS2—epilepsy syndrome	6.73e-05	0.0506	CrCbGaD
Magnesium salicylate—Olsalazine—PTGS2—epilepsy syndrome	6.58e-05	0.0495	CrCbGaD
Magnesium salicylate—Oxcarbazepine—CYP2C19—epilepsy syndrome	6.23e-05	0.0468	CrCbGaD
Magnesium salicylate—Carbamazepine—ABCC2—epilepsy syndrome	6.11e-05	0.0459	CrCbGaD
Magnesium salicylate—Salsalate—PTGS2—epilepsy syndrome	5.59e-05	0.0421	CrCbGaD
Magnesium salicylate—Somnolence—Phenytoin—epilepsy syndrome	5.32e-05	0.000755	CcSEcCtD
Magnesium salicylate—Dyspepsia—Clonazepam—epilepsy syndrome	5.31e-05	0.000752	CcSEcCtD
Magnesium salicylate—Somnolence—Oxcarbazepine—epilepsy syndrome	5.29e-05	0.000751	CcSEcCtD
Magnesium salicylate—Nausea—Clobazam—epilepsy syndrome	5.29e-05	0.00075	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Pregabalin—epilepsy syndrome	5.28e-05	0.000749	CcSEcCtD
Magnesium salicylate—Dyspepsia—Phenytoin—epilepsy syndrome	5.27e-05	0.000747	CcSEcCtD
Magnesium salicylate—Dysgeusia—Valproic Acid—epilepsy syndrome	5.27e-05	0.000747	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Felbamate—epilepsy syndrome	5.27e-05	0.000746	CcSEcCtD
Magnesium salicylate—Anorexia—Lamotrigine—epilepsy syndrome	5.27e-05	0.000746	CcSEcCtD
Magnesium salicylate—Dizziness—Acetazolamide—epilepsy syndrome	5.25e-05	0.000745	CcSEcCtD
Magnesium salicylate—Urticaria—Diazepam—epilepsy syndrome	5.24e-05	0.000743	CcSEcCtD
Magnesium salicylate—Dyspepsia—Oxcarbazepine—epilepsy syndrome	5.24e-05	0.000743	CcSEcCtD
Magnesium salicylate—Decreased appetite—Clonazepam—epilepsy syndrome	5.24e-05	0.000743	CcSEcCtD
Magnesium salicylate—Pruritus—Propofol—epilepsy syndrome	5.22e-05	0.00074	CcSEcCtD
Magnesium salicylate—Tinnitus—Pregabalin—epilepsy syndrome	5.21e-05	0.000738	CcSEcCtD
Magnesium salicylate—Decreased appetite—Phenytoin—epilepsy syndrome	5.2e-05	0.000738	CcSEcCtD
Magnesium salicylate—Flushing—Pregabalin—epilepsy syndrome	5.18e-05	0.000735	CcSEcCtD
Magnesium salicylate—Decreased appetite—Oxcarbazepine—epilepsy syndrome	5.18e-05	0.000734	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Topiramate—epilepsy syndrome	5.16e-05	0.000732	CcSEcCtD
Magnesium salicylate—Pain—Clonazepam—epilepsy syndrome	5.15e-05	0.000731	CcSEcCtD
Magnesium salicylate—Constipation—Clonazepam—epilepsy syndrome	5.15e-05	0.000731	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Zonisamide—epilepsy syndrome	5.15e-05	0.000731	CcSEcCtD
Magnesium salicylate—Hepatitis—Gabapentin—epilepsy syndrome	5.12e-05	0.000726	CcSEcCtD
Magnesium salicylate—Constipation—Phenytoin—epilepsy syndrome	5.12e-05	0.000726	CcSEcCtD
Magnesium salicylate—Pruritus—Midazolam—epilepsy syndrome	5.11e-05	0.000724	CcSEcCtD
Magnesium salicylate—Hallucination—Gabapentin—epilepsy syndrome	5.1e-05	0.000722	CcSEcCtD
Magnesium salicylate—Pain—Oxcarbazepine—epilepsy syndrome	5.09e-05	0.000722	CcSEcCtD
Magnesium salicylate—Constipation—Oxcarbazepine—epilepsy syndrome	5.09e-05	0.000722	CcSEcCtD
Magnesium salicylate—Somnolence—Carbamazepine—epilepsy syndrome	5.08e-05	0.00072	CcSEcCtD
Magnesium salicylate—Urticaria—Felbamate—epilepsy syndrome	5.08e-05	0.00072	CcSEcCtD
Magnesium salicylate—Vomiting—Acetazolamide—epilepsy syndrome	5.05e-05	0.000716	CcSEcCtD
Magnesium salicylate—Diarrhoea—Propofol—epilepsy syndrome	5.05e-05	0.000716	CcSEcCtD
Magnesium salicylate—Pruritus—Levetiracetam—epilepsy syndrome	5.04e-05	0.000715	CcSEcCtD
Magnesium salicylate—Dyspepsia—Carbamazepine—epilepsy syndrome	5.03e-05	0.000713	CcSEcCtD
Magnesium salicylate—Headache—Acetazolamide—epilepsy syndrome	4.98e-05	0.000705	CcSEcCtD
Magnesium salicylate—Urticaria—Zonisamide—epilepsy syndrome	4.97e-05	0.000704	CcSEcCtD
Magnesium salicylate—Decreased appetite—Carbamazepine—epilepsy syndrome	4.97e-05	0.000704	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Clonazepam—epilepsy syndrome	4.97e-05	0.000704	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Phenytoin—epilepsy syndrome	4.93e-05	0.000699	CcSEcCtD
Magnesium salicylate—Somnolence—Lamotrigine—epilepsy syndrome	4.91e-05	0.000696	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	4.91e-05	0.000696	CcSEcCtD
Magnesium salicylate—Weight increased—Topiramate—epilepsy syndrome	4.9e-05	0.000695	CcSEcCtD
Magnesium salicylate—Constipation—Carbamazepine—epilepsy syndrome	4.89e-05	0.000693	CcSEcCtD
Magnesium salicylate—Pain—Carbamazepine—epilepsy syndrome	4.89e-05	0.000693	CcSEcCtD
Magnesium salicylate—Dizziness—Propofol—epilepsy syndrome	4.88e-05	0.000692	CcSEcCtD
Magnesium salicylate—Diarrhoea—Levetiracetam—epilepsy syndrome	4.88e-05	0.000691	CcSEcCtD
Magnesium salicylate—Pruritus—Fosphenytoin—epilepsy syndrome	4.87e-05	0.00069	CcSEcCtD
Magnesium salicylate—Dyspepsia—Lamotrigine—epilepsy syndrome	4.86e-05	0.000689	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Gabapentin—epilepsy syndrome	4.84e-05	0.000686	CcSEcCtD
Magnesium salicylate—Decreased appetite—Lamotrigine—epilepsy syndrome	4.8e-05	0.000681	CcSEcCtD
Magnesium salicylate—Urticaria—Clonazepam—epilepsy syndrome	4.79e-05	0.000679	CcSEcCtD
Magnesium salicylate—Tinnitus—Gabapentin—epilepsy syndrome	4.78e-05	0.000677	CcSEcCtD
Magnesium salicylate—Dizziness—Midazolam—epilepsy syndrome	4.77e-05	0.000677	CcSEcCtD
Magnesium salicylate—Dysgeusia—Pregabalin—epilepsy syndrome	4.76e-05	0.000675	CcSEcCtD
Magnesium salicylate—Urticaria—Phenytoin—epilepsy syndrome	4.76e-05	0.000674	CcSEcCtD
Magnesium salicylate—Pruritus—Vigabatrin—epilepsy syndrome	4.74e-05	0.000673	CcSEcCtD
Magnesium salicylate—Urticaria—Oxcarbazepine—epilepsy syndrome	4.73e-05	0.000671	CcSEcCtD
Magnesium salicylate—Pain—Lamotrigine—epilepsy syndrome	4.72e-05	0.00067	CcSEcCtD
Magnesium salicylate—Constipation—Lamotrigine—epilepsy syndrome	4.72e-05	0.00067	CcSEcCtD
Magnesium salicylate—Nausea—Acetazolamide—epilepsy syndrome	4.72e-05	0.000669	CcSEcCtD
Magnesium salicylate—Dizziness—Levetiracetam—epilepsy syndrome	4.71e-05	0.000668	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Carbamazepine—epilepsy syndrome	4.71e-05	0.000668	CcSEcCtD
Magnesium salicylate—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.71e-05	0.000667	CcSEcCtD
Magnesium salicylate—Vomiting—Propofol—epilepsy syndrome	4.69e-05	0.000665	CcSEcCtD
Magnesium salicylate—Pruritus—Diazepam—epilepsy syndrome	4.67e-05	0.000662	CcSEcCtD
Magnesium salicylate—Rash—Propofol—epilepsy syndrome	4.65e-05	0.000659	CcSEcCtD
Magnesium salicylate—Dermatitis—Propofol—epilepsy syndrome	4.65e-05	0.000659	CcSEcCtD
Magnesium salicylate—Headache—Propofol—epilepsy syndrome	4.62e-05	0.000655	CcSEcCtD
Magnesium salicylate—Vomiting—Midazolam—epilepsy syndrome	4.59e-05	0.000651	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vigabatrin—epilepsy syndrome	4.59e-05	0.00065	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Lamotrigine—epilepsy syndrome	4.55e-05	0.000645	CcSEcCtD
Magnesium salicylate—Rash—Midazolam—epilepsy syndrome	4.55e-05	0.000645	CcSEcCtD
Magnesium salicylate—Dizziness—Fosphenytoin—epilepsy syndrome	4.55e-05	0.000645	CcSEcCtD
Magnesium salicylate—Dermatitis—Midazolam—epilepsy syndrome	4.55e-05	0.000645	CcSEcCtD
Magnesium salicylate—Urticaria—Carbamazepine—epilepsy syndrome	4.54e-05	0.000644	CcSEcCtD
Magnesium salicylate—Vomiting—Levetiracetam—epilepsy syndrome	4.53e-05	0.000642	CcSEcCtD
Magnesium salicylate—Epistaxis—Topiramate—epilepsy syndrome	4.53e-05	0.000642	CcSEcCtD
Magnesium salicylate—Headache—Midazolam—epilepsy syndrome	4.52e-05	0.000641	CcSEcCtD
Magnesium salicylate—Pruritus—Felbamate—epilepsy syndrome	4.52e-05	0.000641	CcSEcCtD
Magnesium salicylate—Diarrhoea—Diazepam—epilepsy syndrome	4.52e-05	0.00064	CcSEcCtD
Magnesium salicylate—Rash—Levetiracetam—epilepsy syndrome	4.49e-05	0.000637	CcSEcCtD
Magnesium salicylate—Dermatitis—Levetiracetam—epilepsy syndrome	4.49e-05	0.000637	CcSEcCtD
Magnesium salicylate—Headache—Levetiracetam—epilepsy syndrome	4.47e-05	0.000633	CcSEcCtD
Magnesium salicylate—Erythema—Gabapentin—epilepsy syndrome	4.46e-05	0.000632	CcSEcCtD
Magnesium salicylate—Dizziness—Vigabatrin—epilepsy syndrome	4.43e-05	0.000629	CcSEcCtD
Magnesium salicylate—Confusional state—Valproic Acid—epilepsy syndrome	4.43e-05	0.000627	CcSEcCtD
Magnesium salicylate—Pruritus—Zonisamide—epilepsy syndrome	4.42e-05	0.000627	CcSEcCtD
Magnesium salicylate—Oedema—Valproic Acid—epilepsy syndrome	4.39e-05	0.000622	CcSEcCtD
Magnesium salicylate—Urticaria—Lamotrigine—epilepsy syndrome	4.39e-05	0.000622	CcSEcCtD
Magnesium salicylate—Nausea—Propofol—epilepsy syndrome	4.38e-05	0.000621	CcSEcCtD
Magnesium salicylate—Vomiting—Fosphenytoin—epilepsy syndrome	4.37e-05	0.00062	CcSEcCtD
Magnesium salicylate—Diarrhoea—Felbamate—epilepsy syndrome	4.37e-05	0.00062	CcSEcCtD
Magnesium salicylate—Dysgeusia—Gabapentin—epilepsy syndrome	4.37e-05	0.000619	CcSEcCtD
Magnesium salicylate—Dizziness—Diazepam—epilepsy syndrome	4.37e-05	0.000619	CcSEcCtD
Magnesium salicylate—Rash—Fosphenytoin—epilepsy syndrome	4.34e-05	0.000615	CcSEcCtD
Magnesium salicylate—Dermatitis—Fosphenytoin—epilepsy syndrome	4.33e-05	0.000614	CcSEcCtD
Magnesium salicylate—Headache—Fosphenytoin—epilepsy syndrome	4.31e-05	0.000611	CcSEcCtD
Magnesium salicylate—Hepatitis—Topiramate—epilepsy syndrome	4.31e-05	0.000611	CcSEcCtD
Magnesium salicylate—Nausea—Midazolam—epilepsy syndrome	4.29e-05	0.000608	CcSEcCtD
Magnesium salicylate—Hallucination—Topiramate—epilepsy syndrome	4.29e-05	0.000608	CcSEcCtD
Magnesium salicylate—Diarrhoea—Zonisamide—epilepsy syndrome	4.28e-05	0.000607	CcSEcCtD
Magnesium salicylate—Pruritus—Clonazepam—epilepsy syndrome	4.26e-05	0.000605	CcSEcCtD
Magnesium salicylate—Vomiting—Vigabatrin—epilepsy syndrome	4.26e-05	0.000604	CcSEcCtD
Magnesium salicylate—Carbamazepine—CYP2C19—epilepsy syndrome	4.24e-05	0.0319	CrCbGaD
Magnesium salicylate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.24e-05	0.000602	CcSEcCtD
Magnesium salicylate—Pruritus—Phenytoin—epilepsy syndrome	4.24e-05	0.000601	CcSEcCtD
Magnesium salicylate—Nausea—Levetiracetam—epilepsy syndrome	4.23e-05	0.0006	CcSEcCtD
Magnesium salicylate—Rash—Vigabatrin—epilepsy syndrome	4.23e-05	0.000599	CcSEcCtD
Magnesium salicylate—Dizziness—Felbamate—epilepsy syndrome	4.23e-05	0.000599	CcSEcCtD
Magnesium salicylate—Dermatitis—Vigabatrin—epilepsy syndrome	4.22e-05	0.000599	CcSEcCtD
Magnesium salicylate—Pruritus—Oxcarbazepine—epilepsy syndrome	4.21e-05	0.000597	CcSEcCtD
Magnesium salicylate—Headache—Vigabatrin—epilepsy syndrome	4.2e-05	0.000596	CcSEcCtD
Magnesium salicylate—Vomiting—Diazepam—epilepsy syndrome	4.2e-05	0.000595	CcSEcCtD
Magnesium salicylate—Anorexia—Valproic Acid—epilepsy syndrome	4.18e-05	0.000593	CcSEcCtD
Magnesium salicylate—Rash—Diazepam—epilepsy syndrome	4.16e-05	0.00059	CcSEcCtD
Magnesium salicylate—Dermatitis—Diazepam—epilepsy syndrome	4.16e-05	0.00059	CcSEcCtD
Magnesium salicylate—Dizziness—Zonisamide—epilepsy syndrome	4.14e-05	0.000586	CcSEcCtD
Magnesium salicylate—Headache—Diazepam—epilepsy syndrome	4.14e-05	0.000586	CcSEcCtD
Magnesium salicylate—Diarrhoea—Clonazepam—epilepsy syndrome	4.12e-05	0.000585	CcSEcCtD
Magnesium salicylate—Hypotension—Valproic Acid—epilepsy syndrome	4.1e-05	0.000581	CcSEcCtD
Magnesium salicylate—Diarrhoea—Phenytoin—epilepsy syndrome	4.1e-05	0.000581	CcSEcCtD
Magnesium salicylate—Nausea—Fosphenytoin—epilepsy syndrome	4.09e-05	0.000579	CcSEcCtD
Magnesium salicylate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.08e-05	0.000578	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Topiramate—epilepsy syndrome	4.07e-05	0.000578	CcSEcCtD
Magnesium salicylate—Vomiting—Felbamate—epilepsy syndrome	4.06e-05	0.000576	CcSEcCtD
Magnesium salicylate—Pruritus—Carbamazepine—epilepsy syndrome	4.04e-05	0.000573	CcSEcCtD
Magnesium salicylate—Rash—Felbamate—epilepsy syndrome	4.03e-05	0.000571	CcSEcCtD
Magnesium salicylate—Dermatitis—Felbamate—epilepsy syndrome	4.03e-05	0.000571	CcSEcCtD
Magnesium salicylate—Tinnitus—Topiramate—epilepsy syndrome	4.02e-05	0.00057	CcSEcCtD
Magnesium salicylate—Headache—Felbamate—epilepsy syndrome	4e-05	0.000567	CcSEcCtD
Magnesium salicylate—Confusional state—Pregabalin—epilepsy syndrome	4e-05	0.000567	CcSEcCtD
Magnesium salicylate—Flushing—Topiramate—epilepsy syndrome	4e-05	0.000567	CcSEcCtD
Magnesium salicylate—Dizziness—Clonazepam—epilepsy syndrome	3.99e-05	0.000565	CcSEcCtD
Magnesium salicylate—Nausea—Vigabatrin—epilepsy syndrome	3.98e-05	0.000565	CcSEcCtD
Magnesium salicylate—Vomiting—Zonisamide—epilepsy syndrome	3.98e-05	0.000564	CcSEcCtD
Magnesium salicylate—Oedema—Pregabalin—epilepsy syndrome	3.97e-05	0.000563	CcSEcCtD
Magnesium salicylate—Dizziness—Phenytoin—epilepsy syndrome	3.96e-05	0.000561	CcSEcCtD
Magnesium salicylate—Rash—Zonisamide—epilepsy syndrome	3.94e-05	0.000559	CcSEcCtD
Magnesium salicylate—Dermatitis—Zonisamide—epilepsy syndrome	3.94e-05	0.000559	CcSEcCtD
Magnesium salicylate—Dizziness—Oxcarbazepine—epilepsy syndrome	3.94e-05	0.000558	CcSEcCtD
Magnesium salicylate—Nausea—Diazepam—epilepsy syndrome	3.92e-05	0.000556	CcSEcCtD
Magnesium salicylate—Headache—Zonisamide—epilepsy syndrome	3.92e-05	0.000555	CcSEcCtD
Magnesium salicylate—Diarrhoea—Carbamazepine—epilepsy syndrome	3.91e-05	0.000554	CcSEcCtD
Magnesium salicylate—Pruritus—Lamotrigine—epilepsy syndrome	3.91e-05	0.000554	CcSEcCtD
Magnesium salicylate—Shock—Pregabalin—epilepsy syndrome	3.9e-05	0.000553	CcSEcCtD
Magnesium salicylate—Somnolence—Valproic Acid—epilepsy syndrome	3.9e-05	0.000553	CcSEcCtD
Magnesium salicylate—Dyspepsia—Valproic Acid—epilepsy syndrome	3.86e-05	0.000548	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.84e-05	0.000544	CcSEcCtD
Magnesium salicylate—Vomiting—Clonazepam—epilepsy syndrome	3.83e-05	0.000543	CcSEcCtD
Magnesium salicylate—Decreased appetite—Valproic Acid—epilepsy syndrome	3.82e-05	0.000541	CcSEcCtD
Magnesium salicylate—Vomiting—Phenytoin—epilepsy syndrome	3.81e-05	0.00054	CcSEcCtD
Magnesium salicylate—Rash—Clonazepam—epilepsy syndrome	3.8e-05	0.000539	CcSEcCtD
Magnesium salicylate—Dermatitis—Clonazepam—epilepsy syndrome	3.8e-05	0.000538	CcSEcCtD
Magnesium salicylate—Nausea—Felbamate—epilepsy syndrome	3.8e-05	0.000538	CcSEcCtD
Magnesium salicylate—Vomiting—Oxcarbazepine—epilepsy syndrome	3.79e-05	0.000537	CcSEcCtD
Magnesium salicylate—Anorexia—Pregabalin—epilepsy syndrome	3.78e-05	0.000536	CcSEcCtD
Magnesium salicylate—Dizziness—Carbamazepine—epilepsy syndrome	3.78e-05	0.000536	CcSEcCtD
Magnesium salicylate—Diarrhoea—Lamotrigine—epilepsy syndrome	3.78e-05	0.000536	CcSEcCtD
Magnesium salicylate—Headache—Clonazepam—epilepsy syndrome	3.78e-05	0.000535	CcSEcCtD
Magnesium salicylate—Rash—Phenytoin—epilepsy syndrome	3.78e-05	0.000535	CcSEcCtD
Magnesium salicylate—Dermatitis—Phenytoin—epilepsy syndrome	3.77e-05	0.000535	CcSEcCtD
Magnesium salicylate—Rash—Oxcarbazepine—epilepsy syndrome	3.76e-05	0.000532	CcSEcCtD
Magnesium salicylate—Constipation—Valproic Acid—epilepsy syndrome	3.75e-05	0.000532	CcSEcCtD
Magnesium salicylate—Pain—Valproic Acid—epilepsy syndrome	3.75e-05	0.000532	CcSEcCtD
Magnesium salicylate—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.000532	CcSEcCtD
Magnesium salicylate—Headache—Phenytoin—epilepsy syndrome	3.75e-05	0.000532	CcSEcCtD
Magnesium salicylate—Erythema—Topiramate—epilepsy syndrome	3.75e-05	0.000532	CcSEcCtD
Magnesium salicylate—Headache—Oxcarbazepine—epilepsy syndrome	3.73e-05	0.000529	CcSEcCtD
Magnesium salicylate—Nausea—Zonisamide—epilepsy syndrome	3.72e-05	0.000527	CcSEcCtD
Magnesium salicylate—Hypotension—Pregabalin—epilepsy syndrome	3.71e-05	0.000526	CcSEcCtD
Magnesium salicylate—Dysgeusia—Topiramate—epilepsy syndrome	3.67e-05	0.000521	CcSEcCtD
Magnesium salicylate—Confusional state—Gabapentin—epilepsy syndrome	3.67e-05	0.00052	CcSEcCtD
Magnesium salicylate—Dizziness—Lamotrigine—epilepsy syndrome	3.65e-05	0.000518	CcSEcCtD
Magnesium salicylate—Oedema—Gabapentin—epilepsy syndrome	3.64e-05	0.000516	CcSEcCtD
Magnesium salicylate—Vomiting—Carbamazepine—epilepsy syndrome	3.63e-05	0.000515	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.62e-05	0.000513	CcSEcCtD
Magnesium salicylate—Rash—Carbamazepine—epilepsy syndrome	3.6e-05	0.000511	CcSEcCtD
Magnesium salicylate—Dermatitis—Carbamazepine—epilepsy syndrome	3.6e-05	0.00051	CcSEcCtD
Magnesium salicylate—Nausea—Clonazepam—epilepsy syndrome	3.58e-05	0.000508	CcSEcCtD
Magnesium salicylate—Headache—Carbamazepine—epilepsy syndrome	3.58e-05	0.000508	CcSEcCtD
Magnesium salicylate—Shock—Gabapentin—epilepsy syndrome	3.58e-05	0.000507	CcSEcCtD
Magnesium salicylate—Nausea—Phenytoin—epilepsy syndrome	3.56e-05	0.000504	CcSEcCtD
Magnesium salicylate—Nausea—Oxcarbazepine—epilepsy syndrome	3.54e-05	0.000502	CcSEcCtD
Magnesium salicylate—Somnolence—Pregabalin—epilepsy syndrome	3.53e-05	0.0005	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.52e-05	0.000499	CcSEcCtD
Magnesium salicylate—Vomiting—Lamotrigine—epilepsy syndrome	3.51e-05	0.000498	CcSEcCtD
Magnesium salicylate—Urticaria—Valproic Acid—epilepsy syndrome	3.49e-05	0.000494	CcSEcCtD
Magnesium salicylate—Rash—Lamotrigine—epilepsy syndrome	3.48e-05	0.000494	CcSEcCtD
Magnesium salicylate—Dermatitis—Lamotrigine—epilepsy syndrome	3.48e-05	0.000493	CcSEcCtD
Magnesium salicylate—Anorexia—Gabapentin—epilepsy syndrome	3.47e-05	0.000492	CcSEcCtD
Magnesium salicylate—Headache—Lamotrigine—epilepsy syndrome	3.46e-05	0.000491	CcSEcCtD
Magnesium salicylate—Oxcarbazepine—ALB—epilepsy syndrome	3.45e-05	0.026	CrCbGaD
Magnesium salicylate—Decreased appetite—Pregabalin—epilepsy syndrome	3.45e-05	0.000489	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—epilepsy syndrome	3.44e-05	0.0259	CrCbGaD
Magnesium salicylate—Hypotension—Gabapentin—epilepsy syndrome	3.4e-05	0.000482	CcSEcCtD
Magnesium salicylate—Nausea—Carbamazepine—epilepsy syndrome	3.39e-05	0.000481	CcSEcCtD
Magnesium salicylate—Constipation—Pregabalin—epilepsy syndrome	3.39e-05	0.000481	CcSEcCtD
Magnesium salicylate—Pain—Pregabalin—epilepsy syndrome	3.39e-05	0.000481	CcSEcCtD
Magnesium salicylate—Nausea—Lamotrigine—epilepsy syndrome	3.28e-05	0.000465	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Pregabalin—epilepsy syndrome	3.27e-05	0.000464	CcSEcCtD
Magnesium salicylate—Somnolence—Gabapentin—epilepsy syndrome	3.23e-05	0.000459	CcSEcCtD
Magnesium salicylate—Dyspepsia—Gabapentin—epilepsy syndrome	3.2e-05	0.000454	CcSEcCtD
Magnesium salicylate—Decreased appetite—Gabapentin—epilepsy syndrome	3.16e-05	0.000448	CcSEcCtD
Magnesium salicylate—Urticaria—Pregabalin—epilepsy syndrome	3.15e-05	0.000447	CcSEcCtD
Magnesium salicylate—Pain—Gabapentin—epilepsy syndrome	3.11e-05	0.000441	CcSEcCtD
Magnesium salicylate—Constipation—Gabapentin—epilepsy syndrome	3.11e-05	0.000441	CcSEcCtD
Magnesium salicylate—Pruritus—Valproic Acid—epilepsy syndrome	3.11e-05	0.00044	CcSEcCtD
Magnesium salicylate—Confusional state—Topiramate—epilepsy syndrome	3.09e-05	0.000438	CcSEcCtD
Magnesium salicylate—Salicylic acid—ALB—epilepsy syndrome	3.06e-05	0.023	CrCbGaD
Magnesium salicylate—Oedema—Topiramate—epilepsy syndrome	3.06e-05	0.000434	CcSEcCtD
Magnesium salicylate—Shock—Topiramate—epilepsy syndrome	3.01e-05	0.000427	CcSEcCtD
Magnesium salicylate—Diarrhoea—Valproic Acid—epilepsy syndrome	3e-05	0.000426	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Gabapentin—epilepsy syndrome	3e-05	0.000425	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Topiramate—epilepsy syndrome	2.96e-05	0.00042	CcSEcCtD
Magnesium salicylate—Salicylic acid—ABCB1—epilepsy syndrome	2.92e-05	0.022	CrCbGaD
Magnesium salicylate—Anorexia—Topiramate—epilepsy syndrome	2.92e-05	0.000414	CcSEcCtD
Magnesium salicylate—Dizziness—Valproic Acid—epilepsy syndrome	2.9e-05	0.000411	CcSEcCtD
Magnesium salicylate—Urticaria—Gabapentin—epilepsy syndrome	2.89e-05	0.00041	CcSEcCtD
Magnesium salicylate—Hypotension—Topiramate—epilepsy syndrome	2.86e-05	0.000406	CcSEcCtD
Magnesium salicylate—Pruritus—Pregabalin—epilepsy syndrome	2.81e-05	0.000398	CcSEcCtD
Magnesium salicylate—Vomiting—Valproic Acid—epilepsy syndrome	2.79e-05	0.000396	CcSEcCtD
Magnesium salicylate—Rash—Valproic Acid—epilepsy syndrome	2.77e-05	0.000392	CcSEcCtD
Magnesium salicylate—Dermatitis—Valproic Acid—epilepsy syndrome	2.76e-05	0.000392	CcSEcCtD
Magnesium salicylate—Headache—Valproic Acid—epilepsy syndrome	2.75e-05	0.00039	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—epilepsy syndrome	2.73e-05	0.0205	CrCbGaD
Magnesium salicylate—Somnolence—Topiramate—epilepsy syndrome	2.72e-05	0.000386	CcSEcCtD
Magnesium salicylate—Diarrhoea—Pregabalin—epilepsy syndrome	2.72e-05	0.000385	CcSEcCtD
Magnesium salicylate—Dyspepsia—Topiramate—epilepsy syndrome	2.69e-05	0.000382	CcSEcCtD
Magnesium salicylate—Decreased appetite—Topiramate—epilepsy syndrome	2.66e-05	0.000377	CcSEcCtD
Magnesium salicylate—Dizziness—Pregabalin—epilepsy syndrome	2.62e-05	0.000372	CcSEcCtD
Magnesium salicylate—Pain—Topiramate—epilepsy syndrome	2.62e-05	0.000371	CcSEcCtD
Magnesium salicylate—Constipation—Topiramate—epilepsy syndrome	2.62e-05	0.000371	CcSEcCtD
Magnesium salicylate—Nausea—Valproic Acid—epilepsy syndrome	2.61e-05	0.00037	CcSEcCtD
Magnesium salicylate—Pruritus—Gabapentin—epilepsy syndrome	2.57e-05	0.000365	CcSEcCtD
Magnesium salicylate—Vomiting—Pregabalin—epilepsy syndrome	2.52e-05	0.000358	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Topiramate—epilepsy syndrome	2.52e-05	0.000358	CcSEcCtD
Magnesium salicylate—Rash—Pregabalin—epilepsy syndrome	2.5e-05	0.000355	CcSEcCtD
Magnesium salicylate—Dermatitis—Pregabalin—epilepsy syndrome	2.5e-05	0.000354	CcSEcCtD
Magnesium salicylate—Diarrhoea—Gabapentin—epilepsy syndrome	2.49e-05	0.000353	CcSEcCtD
Magnesium salicylate—Headache—Pregabalin—epilepsy syndrome	2.49e-05	0.000352	CcSEcCtD
Magnesium salicylate—Urticaria—Topiramate—epilepsy syndrome	2.43e-05	0.000345	CcSEcCtD
Magnesium salicylate—Ketoprofen—ALB—epilepsy syndrome	2.43e-05	0.0183	CrCbGaD
Magnesium salicylate—Dizziness—Gabapentin—epilepsy syndrome	2.41e-05	0.000341	CcSEcCtD
Magnesium salicylate—Nausea—Pregabalin—epilepsy syndrome	2.36e-05	0.000334	CcSEcCtD
Magnesium salicylate—Vomiting—Gabapentin—epilepsy syndrome	2.31e-05	0.000328	CcSEcCtD
Magnesium salicylate—Rash—Gabapentin—epilepsy syndrome	2.29e-05	0.000325	CcSEcCtD
Magnesium salicylate—Dermatitis—Gabapentin—epilepsy syndrome	2.29e-05	0.000325	CcSEcCtD
Magnesium salicylate—Headache—Gabapentin—epilepsy syndrome	2.28e-05	0.000323	CcSEcCtD
Magnesium salicylate—Carbamazepine—ABCB1—epilepsy syndrome	2.25e-05	0.0169	CrCbGaD
Magnesium salicylate—Pruritus—Topiramate—epilepsy syndrome	2.17e-05	0.000307	CcSEcCtD
Magnesium salicylate—Nausea—Gabapentin—epilepsy syndrome	2.16e-05	0.000306	CcSEcCtD
Magnesium salicylate—Diarrhoea—Topiramate—epilepsy syndrome	2.09e-05	0.000297	CcSEcCtD
Magnesium salicylate—Dizziness—Topiramate—epilepsy syndrome	2.02e-05	0.000287	CcSEcCtD
Magnesium salicylate—Vomiting—Topiramate—epilepsy syndrome	1.95e-05	0.000276	CcSEcCtD
Magnesium salicylate—Rash—Topiramate—epilepsy syndrome	1.93e-05	0.000274	CcSEcCtD
Magnesium salicylate—Dermatitis—Topiramate—epilepsy syndrome	1.93e-05	0.000273	CcSEcCtD
Magnesium salicylate—Headache—Topiramate—epilepsy syndrome	1.92e-05	0.000272	CcSEcCtD
Magnesium salicylate—Nausea—Topiramate—epilepsy syndrome	1.82e-05	0.000258	CcSEcCtD
Magnesium salicylate—ALB—Hemostasis—KCNMA1—epilepsy syndrome	1.22e-05	0.000842	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.21e-05	0.000833	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SLC8A1—epilepsy syndrome	1.21e-05	0.000832	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	1.2e-05	0.000824	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—QDPR—epilepsy syndrome	1.2e-05	0.000824	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA4—epilepsy syndrome	1.2e-05	0.000824	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	1.19e-05	0.000822	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.19e-05	0.000818	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	1.18e-05	0.000815	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STX1B—epilepsy syndrome	1.16e-05	0.000802	CbGpPWpGaD
Magnesium salicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	1.15e-05	0.000793	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GBE1—epilepsy syndrome	1.14e-05	0.000787	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	1.14e-05	0.000787	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ADK—epilepsy syndrome	1.14e-05	0.000784	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—L2HGDH—epilepsy syndrome	1.14e-05	0.000784	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—FAR1—epilepsy syndrome	1.14e-05	0.000784	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PDXK—epilepsy syndrome	1.14e-05	0.000784	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GLUD1—epilepsy syndrome	1.14e-05	0.000784	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CERS1—epilepsy syndrome	1.14e-05	0.000784	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.13e-05	0.00078	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	1.13e-05	0.000777	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—COX3—epilepsy syndrome	1.12e-05	0.000775	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	1.12e-05	0.00077	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—epilepsy syndrome	1.12e-05	0.00077	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.12e-05	0.000769	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.12e-05	0.000769	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.1e-05	0.000756	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	1.09e-05	0.000753	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.09e-05	0.000748	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GBE1—epilepsy syndrome	1.08e-05	0.000746	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PPP1R3C—epilepsy syndrome	1.08e-05	0.000746	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CPSF4—epilepsy syndrome	1.08e-05	0.000746	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ASAH1—epilepsy syndrome	1.07e-05	0.00074	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.07e-05	0.000739	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	1.07e-05	0.000735	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PFKL—epilepsy syndrome	1.07e-05	0.000735	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	1.07e-05	0.000735	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—KCNB1—epilepsy syndrome	1.07e-05	0.000735	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	1.07e-05	0.000735	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	1.07e-05	0.000734	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	1.05e-05	0.000723	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.04e-05	0.00072	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—STXBP1—epilepsy syndrome	1.04e-05	0.00072	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	1.04e-05	0.000719	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.04e-05	0.000718	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PNPO—epilepsy syndrome	1.04e-05	0.000717	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GAMT—epilepsy syndrome	1.04e-05	0.000717	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NHLRC1—epilepsy syndrome	1.04e-05	0.000717	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—EPM2A—epilepsy syndrome	1.04e-05	0.000717	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.04e-05	0.000713	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NT5E—epilepsy syndrome	1.02e-05	0.000701	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALAD—epilepsy syndrome	1.02e-05	0.000701	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PPIA—epilepsy syndrome	1.01e-05	0.000699	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.01e-05	0.000695	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.01e-05	0.000695	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—UPB1—epilepsy syndrome	9.75e-06	0.000672	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ATIC—epilepsy syndrome	9.75e-06	0.000672	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NEU1—epilepsy syndrome	9.75e-06	0.000672	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	9.71e-06	0.000669	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	9.71e-06	0.000669	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	9.7e-06	0.000668	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—QDPR—epilepsy syndrome	9.68e-06	0.000667	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA4—epilepsy syndrome	9.68e-06	0.000667	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	9.67e-06	0.000666	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	9.5e-06	0.000655	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	9.39e-06	0.000647	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ADSL—epilepsy syndrome	9.31e-06	0.000641	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ATP2A2—epilepsy syndrome	9.26e-06	0.000638	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	9.21e-06	0.000634	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GLUL—epilepsy syndrome	9.13e-06	0.000629	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—COX3—epilepsy syndrome	9.1e-06	0.000627	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GBE1—epilepsy syndrome	9.07e-06	0.000625	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	9.07e-06	0.000625	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ST3GAL3—epilepsy syndrome	9.01e-06	0.000621	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	8.99e-06	0.00062	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ITGA2—epilepsy syndrome	8.99e-06	0.000619	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	8.96e-06	0.000617	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	8.88e-06	0.000612	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.86e-06	0.00061	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	8.68e-06	0.000598	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	8.67e-06	0.000597	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLCO1A2—epilepsy syndrome	8.63e-06	0.000594	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—KCNB1—epilepsy syndrome	8.63e-06	0.000594	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PFKL—epilepsy syndrome	8.63e-06	0.000594	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CACNA2D2—epilepsy syndrome	8.63e-06	0.000594	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC6A8—epilepsy syndrome	8.63e-06	0.000594	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ASAH1—epilepsy syndrome	8.52e-06	0.000587	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.43e-06	0.000581	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	8.38e-06	0.000577	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.38e-06	0.000577	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—STXBP1—epilepsy syndrome	8.29e-06	0.000571	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.23e-06	0.000567	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AQP1—epilepsy syndrome	8.14e-06	0.000561	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8.12e-06	0.000559	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NT5E—epilepsy syndrome	8.08e-06	0.000557	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALAD—epilepsy syndrome	8.08e-06	0.000557	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.02e-06	0.000552	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ADRA2A—epilepsy syndrome	7.91e-06	0.000545	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NEU1—epilepsy syndrome	7.89e-06	0.000544	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—UPB1—epilepsy syndrome	7.89e-06	0.000544	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ATIC—epilepsy syndrome	7.89e-06	0.000544	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.89e-06	0.000543	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLAT—epilepsy syndrome	7.87e-06	0.000542	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.81e-06	0.000538	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	7.71e-06	0.000531	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	7.71e-06	0.000531	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HSD17B4—epilepsy syndrome	7.59e-06	0.000523	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	7.54e-06	0.00052	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS1—epilepsy syndrome	7.4e-06	0.00051	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ADSL—epilepsy syndrome	7.39e-06	0.000509	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	7.36e-06	0.000507	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CHRM3—epilepsy syndrome	7.36e-06	0.000507	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPP1R3C—epilepsy syndrome	7.33e-06	0.000505	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GBE1—epilepsy syndrome	7.33e-06	0.000505	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GLUL—epilepsy syndrome	7.25e-06	0.000499	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.17e-06	0.000494	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	7.11e-06	0.00049	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	7.07e-06	0.000487	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT3—epilepsy syndrome	6.93e-06	0.000478	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ASAH1—epilepsy syndrome	6.9e-06	0.000475	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.89e-06	0.000475	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.85e-06	0.000472	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLAUR—epilepsy syndrome	6.85e-06	0.000472	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.82e-06	0.00047	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.71e-06	0.000463	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—STXBP1—epilepsy syndrome	6.71e-06	0.000462	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	6.65e-06	0.000458	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EIF2AK2—epilepsy syndrome	6.56e-06	0.000452	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NT5E—epilepsy syndrome	6.54e-06	0.00045	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALAD—epilepsy syndrome	6.54e-06	0.00045	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.5e-06	0.000448	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AQP1—epilepsy syndrome	6.46e-06	0.000445	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CDC42—epilepsy syndrome	6.32e-06	0.000436	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CACNA1A—epilepsy syndrome	6.24e-06	0.00043	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALDH7A1—epilepsy syndrome	6.24e-06	0.00043	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.2e-06	0.000427	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ST3GAL3—epilepsy syndrome	6.1e-06	0.00042	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PPIA—epilepsy syndrome	6.07e-06	0.000418	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCG2—epilepsy syndrome	6e-06	0.000413	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ADSL—epilepsy syndrome	5.98e-06	0.000412	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.9e-06	0.000407	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GLUL—epilepsy syndrome	5.86e-06	0.000404	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	5.85e-06	0.000403	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	5.84e-06	0.000402	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CHRM3—epilepsy syndrome	5.84e-06	0.000402	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	5.81e-06	0.0004	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.77e-06	0.000397	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CACNA1D—epilepsy syndrome	5.76e-06	0.000396	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—FYN—epilepsy syndrome	5.63e-06	0.000388	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.44e-06	0.000375	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—YWHAZ—epilepsy syndrome	5.41e-06	0.000373	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TXNRD1—epilepsy syndrome	5.38e-06	0.000371	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.35e-06	0.000368	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.33e-06	0.000367	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.3e-06	0.000365	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.26e-06	0.000362	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	5.24e-06	0.000361	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AQP1—epilepsy syndrome	5.23e-06	0.00036	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.13e-06	0.000354	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	5.09e-06	0.000351	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.02e-06	0.000346	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	4.99e-06	0.000344	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—BCHE—epilepsy syndrome	4.97e-06	0.000342	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	4.96e-06	0.000342	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLAU—epilepsy syndrome	4.8e-06	0.000331	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCG2—epilepsy syndrome	4.76e-06	0.000328	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	4.74e-06	0.000327	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CHRM3—epilepsy syndrome	4.73e-06	0.000326	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—KCNJ11—epilepsy syndrome	4.73e-06	0.000326	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PLCB1—epilepsy syndrome	4.69e-06	0.000323	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TH—epilepsy syndrome	4.67e-06	0.000322	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	4.64e-06	0.00032	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	4.61e-06	0.000318	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.6e-06	0.000317	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.58e-06	0.000315	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SLC2A1—epilepsy syndrome	4.49e-06	0.00031	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PRKCB—epilepsy syndrome	4.47e-06	0.000308	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JUNB—epilepsy syndrome	4.46e-06	0.000307	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS1—epilepsy syndrome	4.43e-06	0.000305	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS2—epilepsy syndrome	4.41e-06	0.000304	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.4e-06	0.000303	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.4e-06	0.000303	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.31e-06	0.000297	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HBEGF—epilepsy syndrome	4.23e-06	0.000291	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.17e-06	0.000288	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	4.16e-06	0.000287	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT3—epilepsy syndrome	4.15e-06	0.000286	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ADAM10—epilepsy syndrome	4.05e-06	0.000279	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	3.96e-06	0.000273	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—BCHE—epilepsy syndrome	3.95e-06	0.000272	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—HMOX1—epilepsy syndrome	3.9e-06	0.000269	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCG2—epilepsy syndrome	3.85e-06	0.000265	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CAT—epilepsy syndrome	3.85e-06	0.000265	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDC42—epilepsy syndrome	3.78e-06	0.000261	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	3.76e-06	0.000259	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2C19—epilepsy syndrome	3.75e-06	0.000259	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCB1—epilepsy syndrome	3.74e-06	0.000258	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP11A1—epilepsy syndrome	3.73e-06	0.000257	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PLCB1—epilepsy syndrome	3.72e-06	0.000257	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TH—epilepsy syndrome	3.71e-06	0.000256	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.7e-06	0.000255	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GPX1—epilepsy syndrome	3.48e-06	0.00024	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HES1—epilepsy syndrome	3.46e-06	0.000239	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FYN—epilepsy syndrome	3.37e-06	0.000232	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2D6—epilepsy syndrome	3.37e-06	0.000232	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—H2AFX—epilepsy syndrome	3.36e-06	0.000231	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—YWHAZ—epilepsy syndrome	3.24e-06	0.000223	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ADRA2A—epilepsy syndrome	3.21e-06	0.000221	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—BCHE—epilepsy syndrome	3.19e-06	0.00022	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	3.16e-06	0.000218	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CCR5—epilepsy syndrome	3.12e-06	0.000215	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HMOX1—epilepsy syndrome	3.1e-06	0.000213	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CAT—epilepsy syndrome	3.06e-06	0.00021	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AGT—epilepsy syndrome	3.05e-06	0.00021	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC2A1—epilepsy syndrome	3.05e-06	0.00021	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PLCB1—epilepsy syndrome	3.01e-06	0.000208	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TH—epilepsy syndrome	3e-06	0.000207	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—APOE—epilepsy syndrome	2.99e-06	0.000206	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCB1—epilepsy syndrome	2.97e-06	0.000205	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.95e-06	0.000204	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TSC2—epilepsy syndrome	2.9e-06	0.0002	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APOE—epilepsy syndrome	2.83e-06	0.000195	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GPX1—epilepsy syndrome	2.76e-06	0.00019	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6ST—epilepsy syndrome	2.66e-06	0.000183	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS2—epilepsy syndrome	2.64e-06	0.000182	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SRC—epilepsy syndrome	2.62e-06	0.000181	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—POMC—epilepsy syndrome	2.57e-06	0.000177	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.56e-06	0.000176	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HMOX1—epilepsy syndrome	2.51e-06	0.000173	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CAT—epilepsy syndrome	2.47e-06	0.00017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AGT—epilepsy syndrome	2.42e-06	0.000167	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCB1—epilepsy syndrome	2.4e-06	0.000166	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—APOE—epilepsy syndrome	2.37e-06	0.000164	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALB—epilepsy syndrome	2.34e-06	0.000161	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GPX1—epilepsy syndrome	2.24e-06	0.000154	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF2—epilepsy syndrome	2.15e-06	0.000148	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.05e-06	0.000141	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—POMC—epilepsy syndrome	2.04e-06	0.00014	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTOR—epilepsy syndrome	1.96e-06	0.000135	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AGT—epilepsy syndrome	1.96e-06	0.000135	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—APOE—epilepsy syndrome	1.92e-06	0.000132	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALB—epilepsy syndrome	1.86e-06	0.000128	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—POMC—epilepsy syndrome	1.65e-06	0.000114	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—epilepsy syndrome	1.63e-06	0.000112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SRC—epilepsy syndrome	1.57e-06	0.000108	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—epilepsy syndrome	1.32e-06	9.07e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.03e-06	7.09e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—epilepsy syndrome	9.76e-07	6.72e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—epilepsy syndrome	8.17e-07	5.63e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—epilepsy syndrome	6.61e-07	4.56e-05	CbGpPWpGaD
